Mark G. Currie, President at Cyclerion Therapeutics, Inc. (CYCN), sold 75,000 shares at $2.55 ($190K) on 2019-12-27, disclosed to the SEC on 2019-12-31.
Open-market sale of $190k CYCN by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.55 | 25,000 | $64K | 33.6% |
| 2 | $2.55 | 25,000 | $64K | 33.6% |
| 3 | $2.48 | 25,000 | $62K | 32.7% |
| Total | $2.53 avg | 75,000 | $190K | 100% |
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| CYCN | SELL | 2020-12-30 | $121K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |